As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
North America's first B Corp Certified General Contractor, Advancing Collaboration and Innovation in Construction with Integrated Project Delivery (IPD) - Tim Coldwell, President, Chandos Construction
Built Environment Matters
35 minutes
3 years ago
North America's first B Corp Certified General Contractor, Advancing Collaboration and Innovation in Construction with Integrated Project Delivery (IPD) - Tim Coldwell, President, Chandos Construction
This episode Bryden Wood Head of Global Systems Jaimie Johnston MBE is joined by Tim Coldwell, President of Canada's Chandos Construction. Tim talks about being purpose-driven, 100% employee-owned, and the first and largest B Corp certified commercial general contractor in North America. In addition to recycling construction waste on 100% of projects, Chandos is also working to advance collaboration and innovation in the construction industry through Integrated Project Delivery (IPD). Se...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
